Your Messages Inbox
Your Article Summary
See Latest ArticlesNew Data Proves Effectiveness of Medtronic Insertable Cardiac Monitor in Detecting AF, Most Common Heart Rhythm Disorder
Medtronic, 06/24/09
Atrial fibrillation is the most common arrhythmia, affecting an estimated 7 million people worldwide, including 4.5 million in the European Union. Data presented today as a Hot Line session at the EUROPACE 2009 congress on the XPECT clinical trial, sponsored by Medtronic, Inc. , shows that the Medtronic Reveal XT Insertable Cardiac Monitor reliably identifies patients with AF and correctly confirms the absence of AF in patients.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
GSK study showed targeted therapy combination achieved 14 month overall survival in patients with advanced breast cancer
GlaxoSmithKline, 12/15/09
New Phase II Study Showed Trastuzumab-DM1 Shrank Tumors in Women With Highly Advanced HER2-positive Breast Cancer
Genentech, 12/15/09
GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines
GlaxoSmithKline, 12/15/09
Article Search
Sponsor